← All trials
NCT00293423
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2005
- Primary completion
- Aug 1, 2013
- Completion date
- Aug 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 41
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of California, San FranciscoLead sponsor
- University of California, San FranciscoStudy chair
- National Cancer Institute (NCI)Collaborator
- Agenus Inc.Collaborator
- University of California, San FranciscoReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.